Last $0.12 USD
Change Today 0.00 / 0.00%
Volume 95.8K
MYOS On Other Exchanges
Symbol
Exchange
OTC US
As of 11:15 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

myos corp (MYOS) Snapshot

Open
$0.12
Previous Close
$0.12
Day High
$0.12
Day Low
$0.12
52 Week High
06/20/12 - $0.50
52 Week Low
04/8/13 - $0.08
Market Cap
13.4M
Average Volume 10 Days
274.1K
EPS TTM
--
Shares Outstanding
111.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MYOS CORP (MYOS)

Related News

No related news articles were found.

myos corp (MYOS) Related Businessweek News

No Related Businessweek News Found

myos corp (MYOS) Details

MYOS Corporation, a development stage company, focuses on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining or improving the health and performance of muscle tissue. It develops MYO-T12, a natural-myostatin inhibitor that is used to optimize biological activity. The company was formerly known as Atlas Therapeutics Corporation and changed its name to MYOS Corporation in May 2012. MYOS Corporation was founded in 2007 and is based in Cedar Knolls, New Jersey.

4 Employees
Last Reported Date: 03/29/13
Founded in 2007

myos corp (MYOS) Top Compensated Officers

President and Chief Operating Officer
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2012.

myos corp (MYOS) Key Developments

MYOS Corp. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013

MYOS Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported revenue of $277,374 against $24,541 a year ago. Loss from operations was $1,092,059 against $423,024 a year ago. Net loss was $1,090,194 against $498,851 a year ago. Basic and diluted net loss per share attributable to common stockholders was $0.01 against $0.01 a year ago.

MYOS Corp. Announces Management Changes

On April 25, 2013, Glen R. Fleischer resigned from his position as Chief Executive Officer of MYOS Corporation and as a member of its board of directors. On April 21, 2013, Peter Levy, the company’s existing Chief Operating Officer, was appointed to the additional position of President of the company. In this capacity, Mr. Levy will serve as the company’s principal executive officer.

MYOS Corp. Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2012

MYOS Corp. reported consolidated earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, the company reported revenue of $177,364 against $43,634 a year ago. Loss from operations was $1,021,884 against $896,503 a year ago. Net loss was $1,018,174 against $1,807,227 a year ago. For the year, the company reported revenue of $911,727 against $99,475 a year ago. Loss from operations was $3,035,493 against $4,596,220 a year ago. Net loss was $3,914,460 against $5,597,300 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYOS:US $0.12 USD 0.00

MYOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MYOS.
View Industry Companies
 

Industry Analysis

MYOS

Industry Average

Valuation MYOS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11.8x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYOS CORP, please visit www.myoscorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.